Диссертация (1102418), страница 29
Текст из файла (страница 29)
- 208-210 с.242.Waage A., Aasen A.D. Different role of cytokine mediators in septic shockrelated to meningococcal disease and surgery/polytrauma // Immunol. Rev. 1992. - 127. - P. 221-230.243.Lin J.-S., Huang J.H., Hung L.-Y., et al. Distinct roles of complementreceptor 3, Dectin-1, and sialic acids in murine macrophage interaction withhistoplasmayeast // Journal of Leukocyte Biology. - 2010. - V. 88. - № 1. P. 95-106.244.Генералов Е.А., Левашова Н.Т., Сидорова А.Э., Чумаков П.М., ЯковенкоЛ.В.Автоволноваятрансформированныхмодельклетокбифуркационногоподдействиемповеденияполисахарида//Биофизика.
- 2017. - Т. 62. - № 5. - С. 876-881.245.Schütze S., Tchikov V., Schneider-Brachert W. Regulation of TNFR1 andCD95 signalling by receptor compartmentalization // Molecular cell biology.- 2008. - V. - 9. - P. 665-662.246.Eyring H., Eyring E.M. Modern chemical kinetics. – N.Y.: ReinholdPublishing Corporation, - 1963.247.FitzHugh R. Impulses and physiological states in theoretical model of nervemembrane // Biophysics Journal. - 1961. - V.
1. - № 6. - P. 445-466.248.Сидорова А.Э., Левашова Н.Т., Мельникова А.А., Семина А.Е. Модельструктурообразованияурбоэкосистемкакпроцессавтоволновойсамоорганизации в активных средах // Математическая биология ибиоинформатика. - 2017. - V. 12. - № 1 - P.
186-197.249.Li Q., Ching A.K., Chan B.C., et al. A Death Receptor-associated Antiapoptotic Protein, BRE, Inhibits Mitochondrial Apoptotic Pathway // TheJournal of Biological Chemistry. - 2004. - V. 279. - P. 52106-52116.184250.Underhill D.M., Rossnagle E., Lowell C.A., Simmons R.M. Dectin-1activates Syk tyrosine kinase in a dynamic subset of macrophages forreactive oxygen production // Blood. - 2005.
- V. 106. - № 7, 2543-2550.251.Ranjan K., Pathaka C. FADD regulates NF-κB activation and promotesubiquitination of cFLIPL to induce apoptosis // Sci Rep. - 2016. - V. 6. - P.22787.252.Fallahi-Sichani M., Schaller M.A., Kirschner D.E., et al. Identification ofkey processes that control tumor necrosis factor availability in a tuberculosisgranuloma // PLoS Comput Biology. - 2010.
- V. 6. - № 5. e1000778.253.Palma A.S., Feizi T., Zhang Y., et al. Ligands for the β-glucan receptor,Dectin-1, assigned using “designer” microarrays of oligosaccharide probes(neoglycolipids) generated from glucan polysaccharides // The Journal ofBiological Chemistry. - 2006. - V. 281. - P. 5771-5779.254.Galès A., Conduché A., Bernad J., et al.
PPARγ controls Dectin-1expression required for host antifungal defense against Candida albicans //PLoS Pathog. - 2010. - V. 6. - № 1. e1000714.255.Taylor P.R., Roy S., Leal S.M.Jr., et al. Activation of neutrophils byautocrine IL-17A–IL-17RC interactions during fungal infection is regulatedby IL-6, IL-23, RORγt and dectin-2 // Nature Immunology. - 2014. - V. 15. P.
143-151.256.Hajjar A.M., O’Mahony D.S., Ozinsky A., et al. Cutting Edge: Functionalinteractions between Toll-like receptor (TLR) 2 and TLR1 or TLR6 inresponse to phenol-soluble modulin / // The Journal of Immunology. - 2001.- V. 166. - № 1. - P. 15-19.257.Nishiya T., DeFranco A.L. Ligand-regulated chimeric receptor approachreveals distinctive subcellular localization and signaling properties of theToll-like receptors // The Journal of Biological Chemistry.
- 2004. - V. 279.- P. 19008-19017.185258.Gnesutta N., Minden A. Death receptor-induced activation of initiatorCaspase 8 is antagonized by serine/threonine kinase PAK4 // Molecular CellBiology. - 2003. - V. 23. - № 21. - P. 7838-7848.259.Woods C.R. Trends in DNA research – N.Y.: Nova Biomedical Books, 2006.260.Dennehy K.M., Ferwerda G., Faro-Trindade I., et al.
Syk kinase is requiredfor collaborative cytokine production induced through Dectin-1 and Tolllike receptors // Eur J Immunol. - 2008. - V. 38. № 2. - P. 500-506.261.Генералов Е.А. Природные полисахариды. – Германия: LAP LambertPublishing, - 2014. - 87 с.262.Kačuráková M., Wilson R.H. Developments in mid-infrared FT-IRspectroscopy of selected carbohydrates // Carbohydr. Pol. - 2001. - V.
44. Р. 291.263.Haxaire K., Maréchal Y., Milas M., Rinaudo M. Hydration of polysaccharidehyaluronan observed by IR spectrometry. I. Preliminary experiments andband assignments / // Biopolymers. - 2003. - V. 72. - № 1. - P. 10-20.264.Москвин А.В. Новый справочник химика и технолога. Аналитическаяхимия. Часть 3. – С.-П.: АНО НПО «Профессионал», - 2004. - 692 с.265.Купцов А.Х., Жижин Г.Н.
Фурье-КР и Фурье-ИК спектры полимеров. –М.: Техносфера, - 2013. - 696 с.266.Jansson P.–E., Kenne L., Widmalm G. Casper—a computerised approach tostructure determination of polysaccharides using information from n.m.r.spectroscopy and simple chemical analyses // Carbohydrate research. - 1987.- V.
168. - P. 67-77.267.Генералов Е.А. Структура и радиопротекторные свойства нетоксичногополисахарида из Helianthus tuberosus L. Биофизика. - 2014. - Т. 59. - №3. - С. 439-445.268.Генералов Е.А. Спектральные характеристики и моносахаридныйсостав противовирусного полисахаридного индуктора интерферона изHelianthus Tuberosus L. // Биофизика. - 2015. - Т. 60.
- № 1. - С. 65-72.186269.Генералов Е.А. Стимуляция антителообразующих клеток природнымполисахаридом из Helianthus Tuberosus L. // СПСРФФ. Тезисыконференции. - 2015. - С. 146-148.270.Рождественский Л.М. Применение рекомбинантного человеческогоинтерлейкина-1β (Беталейкина) для экстренной терапии остройлучевой болезни тяжелой степени у собак // Радиац. биология. Радиоэкология. - 2008. - Т. 48. - № 2. - С.
185–194.271.Кудряшов Ю.Б. Химическая защита от лучевого поражения //Соросовский образовательный журнал. - 2000. - Т. 6. - С. 21–26.272.ГенераловЕ.А.Водно-растворимыйtuberosusL.:радиозащитная,полисахаридизHelianthusколониестимулирующаяииммуномодулирующая активность // Биофизика. - 2015.
- Т. 60. - № 1. С. 73-79.273.Генералов Е.А., Генералова Л.В. Влияние полисахарида из Helianthustuberosus L. а число клеток линии RAW 264.7 и синтез TNF-α. VIIIМеждународнаяНаучнаяКонференцияSCIENCE4HEALTH2017.Тезисы конференции. - 2017. - С. 270.274.Генералов Е.А., Афремова А.И. Молекулярный механизм действияполисахарида из Helianthus tuberosus L.
// Биофизика. - 2016. - Т. 61. № 4. - С. 660-668.275.Sadahiro A., Diogo C.L., Oshiro T.M., Shikanai-Yasuda M.A. Kinetics ofIFN-gamma, TNF-alpha, IL-10 and IL-4 production by mononuclear cellsstimulated with gp43 peptides, in patients cured of paracoccidioidomycosis// Rev. Soc. Bras. Med. Trop. - 2007. - V. 40. - № 2.
- P. 156-162.276.Generalov E.A. Antimetastatic and Tumor Growth Inhibition Activity ofPolysaccharide from Helianthus Tuberosus L. // International journal ofcancer prevention research. - 2015. - V. 1. - № 1. - P. 5-10.277.Yadomae T., Zasshi Y. Structure and biological activities of fungal beta-1,3glucans // Journal of the Pharmaceutical Society of Japan. - 2000. - V. 120. P. 413-431.187278.Генералов Е.А. Физико-химические подходы к анализу природныхполисахаридов // AUDITORIUM. - 2015. - Т.
4. - № 8. - С. 1-17.279.El Enshasy H.A., Hatti-Kaul R. Mushrooms: A potential natural source ofanti-inflammatory compounds for medical applications // Trends inbiotechnology. - 2013. - V. 31. - P. 668-677.280.Paterson R.R.M., Lima N. Biomedical effects of mushrooms with emphasison pure compounds // Biomedical journal. - 2014. - V. 37. - P.
357-368.281.MizunoT.Theextractionanddevelopmentofantitumor-activepolysaccharides from medicinal mushrooms in Japan (review) // Int. J. Med.Mushrooms. - 1999. - V. 1. - P. 9-29.282.Gao Q.-P., Jiang R.-Z., Chen H.-Q., et al. Characterization and cytokinestimulating activities of heteroglycans from Tremella fuciformis // PlantaMed. - 1996. - V. 62. - P. 297-302.283.Leung M.Y.K., Fung K.P., Choy Y.M. The isolation and characterization ofan immunomodulatory and anti-tumor polysaccharide preparation fromFlammulina velutipes // Immunopharmacol. - 1997.
- V. 35. - № 3. - P. 255263.284.Benencia F., Courreges M.C., Coulombie F.C. In vivo and in vitroimmunomodulatory activities of Trichilia glabra aqueous leaf extracts // J.Ethnopharmacol. - 2000. - V. 69. - P. 199–205.285.Roubroeks J.P., Mastromauro D.I., Andersson R., et al. Molecular weight,structure, and shape of oat (1–>3), (1–>4)-beta-D-glucan fractions obtainedby enzymatic degradation with lichenase // Biomacromolecules.
- 2000. - V.1. - P. 584–591.286.Lu Y.C., Yeh W.C., Ohashi P.S. LPS/TLR4 signal transduction pathway //Cytokine. - 2008. - V. 42. - № 2. - P. 145-151.287.Franz G. Polysaccharide in pharmacy: current applications and futureconcepts // Planta Medica. - 1989. - V. 55. - P. 493–497.188288.Bohn J.A., BeMiller J.N. (1–3)-β-D-glucans as biological responsemodifiers: A review of structure-functional activity relationships //Carbohydrate polymers. - 1995.
- V. 28. - P. 3-14.289.Wan L., Pantel K., Kang Y. Tumor metastasis: moving new biologicalinsights into the clinic // Nat Med. - 2013. - V. 19. - P. 1450–1464.290.Iurisci I., Tinari N., Natoli C., et al. Concentrations of galectin-3 in the seraof normal controls and cancer patients / // Clin. Cancer Res. - 2000. - V. 6. P. 1389–1393.291.Liu F.T., Rabinovich G.A. Galectins as modulators of tumor progression //Nat. Rev. Cancer. - 2005. - V.
5. - P. 29–41.292.Thijssen V.L., Poirier F., Baum L.G., Griffioen A.W. Galectins in the tumorendothelium: opportunities for combined cancer therapy // Blood. - 2007. V. 110. - P. 2819–2827.293.Fukumori T., Takenaka Y., Yoshii T., et al. CD29 and CD7 mediate galectin3-induced type II T-cell apoptosis / // Cancer Res. - 2003. - V. 63. - P. 8302–8311.294.Gao X., Zhi Y., Lin Z., et al. The inhibitory effects of a rhamnogalacturonanΙ (RG-I) domain from ginseng pectin on galectin-3 and its structure-activityrelationship // J. Biol. Chem.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
